AV-1

AV-1 · AbViro LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AV-1, covering 2022-10-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection [Phase 2]